永胜医疗发盈喜，预期年度股东应占综合溢利不少于1亿港元 同比增加

Core Viewpoint - Yongsheng Medical (01612) anticipates an unaudited consolidated profit attributable to shareholders of no less than HKD 100 million for the year ending December 31, 2025, compared to an audited profit of approximately HKD 69.2 million for the year ending December 31, 2024 [1] Group 1 - The expected profit increase is primarily attributed to strengthened relationships with a major customer in the imaging disposable products segment and the expansion of business scale [1] - The company has achieved better economies of scale by enhancing capacity utilization and operational efficiency, leading to improved gross margins [1]